Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $392.09 million. The enterprise value is $193.05 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ALLO has 209.67 million shares outstanding. The number of shares has increased by 22.14% in one year.
Current Share Class | 209.67M |
Shares Outstanding | 209.67M |
Shares Change (YoY) | +22.14% |
Shares Change (QoQ) | +10.08% |
Owned by Insiders (%) | 8.12% |
Owned by Institutions (%) | 70.29% |
Float | 151.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 10,294.56 |
PB Ratio | 0.84 |
P/TBV Ratio | 0.85 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4,489.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.35, with a Debt / Equity ratio of 0.20.
Current Ratio | 9.35 |
Quick Ratio | 9.04 |
Debt / Equity | 0.20 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,688.56 |
Financial Efficiency
Return on equity (ROE) is -54.15% and return on invested capital (ROIC) is -27.19%.
Return on Equity (ROE) | -54.15% |
Return on Assets (ROA) | -25.82% |
Return on Capital (ROIC) | -27.19% |
Revenue Per Employee | $185 |
Profits Per Employee | -$1.22M |
Employee Count | 233 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.46% in the last 52 weeks. The beta is 0.83, so ALLO's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | -37.46% |
50-Day Moving Average | 2.48 |
200-Day Moving Average | 2.85 |
Relative Strength Index (RSI) | 36.26 |
Average Volume (20 Days) | 2,703,139 |
Short Selling Information
The latest short interest is 31.17 million, so 14.87% of the outstanding shares have been sold short.
Short Interest | 31.17M |
Short Previous Month | 35.05M |
Short % of Shares Out | 14.87% |
Short % of Float | 20.52% |
Short Ratio (days to cover) | 11.46 |
Income Statement
In the last 12 months, ALLO had revenue of $43,000 and -$283.43 million in losses. Loss per share was -$1.54.
Revenue | 43,000 |
Gross Profit | -201.95M |
Operating Income | -268.86M |
Pretax Income | -281.93M |
Net Income | -283.43M |
EBITDA | -254.97M |
EBIT | -268.86M |
Loss Per Share | -$1.54 |
Full Income Statement Balance Sheet
The company has $291.56 million in cash and $92.52 million in debt, giving a net cash position of $199.04 million or $0.95 per share.
Cash & Cash Equivalents | 291.56M |
Total Debt | 92.52M |
Net Cash | 199.04M |
Net Cash Per Share | $0.95 |
Equity (Book Value) | 463.75M |
Book Value Per Share | 2.21 |
Working Capital | 271.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$217.31 million and capital expenditures -$618,000, giving a free cash flow of -$217.93 million.
Operating Cash Flow | -217.31M |
Capital Expenditures | -618,000 |
Free Cash Flow | -217.93M |
FCF Per Share | -$1.04 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -625,246.51% |
Pretax Margin | -659,137.21% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.14% |
Shareholder Yield | -22.14% |
Earnings Yield | -72.29% |
FCF Yield | -55.58% |
Analyst Forecast
The average price target for ALLO is $10.06, which is 437.97% higher than the current price. The consensus rating is "Buy".
Price Target | $10.06 |
Price Target Difference | 437.97% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 319.90% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -2.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.4 |
Piotroski F-Score | 3 |